The U.S. market for medicines grew by 5% in 2022, reaching a total value of $429Bn on a net price basis. This was driven by a range of factors, including an increase in health services utilization, which is now back to pre-pandemic levels, and the entry of new medicines into the market. Balancing these drivers of growth, was a lack of net price increases for branded drugs and patient out-of-pocket costs per retail prescription remaining under $10. This is according to a new report from the IQVIATM Institute for Human Data Science, The Use of Medicines in the U.S. 2023: Usage and Spending Trends and Outlook to 2027.
Read the full article: Use of Medicines in the U.S. Continued to Grow in 2022 //
Source: https://www.businesswire.com/news/home/20230502005241/en/Use-of-Medicines-in-the-U.S.-Continued-to-Grow-in-2022-while-Patient-Out-of-Pocket-Costs-Remain-Low-Says-IQVIA-Institute